Company intelligence / Profile preview

FatiAbGen

Zurich*, Zurich, Switzerlandfatiabgen.com ↗

Ownership: Private
Development stage: Preclinical

Overview

FatiAbGen is a preclinical-stage biotech company focused on developing best-in-class monoclonal and multi-modality antibodies for high unmet need indications in oncology and immunology. The company has developed novel ADCs targeting difficult cancers such as pancreatic and ovarian cancer as well as preclinical assets for allergy/asthma. It leverages advanced antibody engineering platforms and AI-driven design partnerships to optimize safety and efficacy. No clinical results have been reported yet.

Therapeutic areas: OncologyImmunology
Modalities: Monoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Bispecific antibodiesFusion protein antibody drug conjugates
Industry: Biotech

Partnerships

Ordaōs Bio – collaboration to optimize monoclonal antibodies using AI/machine learning for challenging oncology conditions including pancreatic/ovarian cancers.CDMOs with unique value propositions are sought as partners.

Beyond the preview

Go deeper on FatiAbGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FatiAbGen.

Explore the full profile